Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14687)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pascual S, Herrera I, Irurzun J. New advances in hepatocellular carcinoma. World J Hepatol 2016; 8(9): 421-438 [PMID: 27028578 DOI: 10.4254/wjh.v8.i9.421] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i9/421.htm |
| Number | Citing Articles |
| 1 |
Meimei Wu, Qi Zhu, Lingling Chen, Dong Yan. Bilious pleuritis due to hepatic microwave ablation. Medicine 2020; 99(44): e22763 doi: 10.1097/MD.0000000000022763
|
| 2 |
Sara Blasco-Algora, José Masegosa-Ataz, Sonia Alonso, Maria-Luisa Gutiérrez, Conrado Fernández-Rodriguez. Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterology 2016; 3(1): e000104 doi: 10.1136/bmjgast-2016-000104
|
| 3 |
Saima Ali Haider, Bashir Ahmad, Sajid Ali, Ali Haider, Shumaila Bashir, Nourin Mahmood. Sofosbuvir and Ribavirin Combination Therapy Response in Various Hepatitis C Virus Genotypes in Peshawar, Khyber Pakhtunkhwa. Jundishapur Journal of Microbiology 2020; 13(6) doi: 10.5812/jjm.99625
|
| 4 |
Dingquan Yang, Fujian Ji, Yanqing Li, Yan Jiao, Xuedong Fang. GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820945817
|
| 5 |
Chao Zheng, Jin Liang, Shoude Yu, Hua Xu, Lin Dai, Dan Xu. Circ-SNX27 sponging miR-375/RPN1 axis contributes to hepatocellular carcinoma progression. The Korean Journal of Physiology & Pharmacology 2023; 27(4): 333 doi: 10.4196/kjpp.2023.27.4.333
|
| 6 |
Min Shi, Ye Jiang, Lu Yang, Shushan Yan, Yu‐Gang Wang, Xiao‐Jie Lu. Decreased levels of serum exosomal miR‐638 predict poor prognosis in hepatocellular carcinoma. Journal of Cellular Biochemistry 2018; 119(6): 4711 doi: 10.1002/jcb.26650
|
| 7 |
Hongyu Liu, Baoguo Li. The functional role of exosome in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2018; 144(11): 2085 doi: 10.1007/s00432-018-2712-7
|
| 8 |
Shan Huang, Da Zhou, Yu‐Xuan Li, Zhi‐Yong Ming, Ke‐Zhi Li, Guo‐Bin Wu, Chuang Chen, Yin‐Nong Zhao. Retracted: In vivo and in vitro effects of microRNA‐221 on hepatocellular carcinoma development and progression through the JAK–STAT3 signaling pathway by targeting SOCS3. Journal of Cellular Physiology 2019; 234(4): 3500 doi: 10.1002/jcp.26863
|
| 9 |
Suchita Dattatray Shinde, Neeraj Kulkarni, Bichismita Sahu, Kiran Kalia, Santosh Kumar Behera. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 149 doi: 10.1016/B978-0-323-98807-0.00007-7
|
| 10 |
Pin Liu, Mengmeng Ge, Junjie Hu, Xiaolei Li, Li Che, Kun Sun, Lili Cheng, Yuedong Huang, Maria G. Pilo, Antonio Cigliano, Giovanni M. Pes, Rosa M. Pascale, Stefania Brozzetti, Gianpaolo Vidili, Alberto Porcu, Antonio Cossu, Giuseppe Palmieri, Maria C. Sini, Silvia Ribback, Frank Dombrowski, Junyan Tao, Diego F. Calvisi, Ligong Chen, Xin Chen. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis. Hepatology 2017; 66(1): 167 doi: 10.1002/hep.29183
|
| 11 |
Afaf R. El-sherbeni, Maivel H. Ghattas, Hanan H. Shehata, Magda I. Mohamad. Silencing the epitranscriptomic writer METTL3 in Hepatocellular carcinoma cells: A prospective therapeutic approach. Gene Reports 2021; 25: 101359 doi: 10.1016/j.genrep.2021.101359
|
| 12 |
Muhammad Shahzad Afzal, Muhammad Babar Imran, Muhammad Saeed Akhtar, Muhammad Iqbal. Increased renal parenchymal retention of 99mTc-MDP (hot kidneys) in two patients of Hepatocellular Cancer: one with and other without osseous metastases. European Journal of Medical Case Reports 2017; 1(2) doi: 10.24911/ejmcr/1/19
|
| 13 |
Brandon M. Meyers, Arndt Vogel, Paul Marotta, Petr Kavan, Laveena Kamboj, Janice Pan, Marc Geadah, David Trueman, Suthakar Sabapathy, Alessandro Granito. The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8811018
|
| 14 |
Antonio Cigliano, Maria G. Pilo, Lei Li, Gavinella Latte, Marta Szydlowska, Maria M. Simile, Panagiotis Paliogiannis, Li Che, Giovanni M. Pes, Giuseppe Palmieri, Maria C. Sini, Antonio Cossu, Alberto Porcu, Gianpaolo Vidili, Maria A. Seddaiu, Rosa M. Pascale, Silvia Ribback, Frank Dombrowski, Xin Chen, Diego F. Calvisi. Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis. Oncotarget 2017; 8(53): 90638 doi: 10.18632/oncotarget.21469
|
| 15 |
Lan Zhang, Kesheng Wang, Qing Deng, Wei Li, Xiaofeng Zhang, Xing Liu. Identification of Key Hydroxymethylated Genes and Transcription Factors Associated with Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. DNA and Cell Biology 2019; 38(11): 1346 doi: 10.1089/dna.2019.4689
|
| 16 |
Alicia Bort, Elena Spínola, Nieves Rodríguez-Henche, Inés Díaz-Laviada. Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation. Oncotarget 2017; 8(50): 87684 doi: 10.18632/oncotarget.21196
|
| 17 |
Néstor Prieto‐Domínguez, Raquel Ordóñez, Anna Fernández, Carolina Méndez‐Blanco, Anna Baulies, Carmen Garcia‐Ruiz, José C. Fernández‐Checa, José L. Mauriz, Javier González‐Gallego. Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. Journal of Pineal Research 2016; 61(3): 396 doi: 10.1111/jpi.12358
|
| 18 |
Heba Hany, Asem Shalaby, Wagdi Al Kashef, Wageha Kandil, Rehab-Allah Shahin, Hatem El-Alfy, Tarek Besheer, Raghda Farag, Mie Mohamed. Evaluation of the role of Notch1 expression in hepatic carcinogenesis with clinico-pathological correlation. Pathology 2018; 50(7): 730 doi: 10.1016/j.pathol.2018.08.007
|
| 19 |
|
| 20 |
Jianming Shen, Hui Shen, Lixin Ke, Jialin Chen, Xi Dang, Baoxian Liu, Yunpeng Hua. Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.815575
|
| 21 |
Mohammad H. Fard-Aghaie, Johannes Laengle, Kim C. Wagner, Tim Reese, Sebastian Wirtz, Karl J. Oldhafer. Liver surgery in the 2020s: ante-situm and in-situ resection are still indicated – A single-center study. HPB 2023; 25(9): 1030 doi: 10.1016/j.hpb.2023.05.365
|
| 22 |
Josep M. Llovet, Amit G. Singal, Augusto Villanueva, Richard S. Finn, Masatoshi Kudo, Peter R. Galle, Masafumi Ikeda, Sophie Callies, Louise M. McGrath, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Elena Gonzalez-Gugel, Andrew X. Zhu. Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials. Clinical Cancer Research 2022; 28(11): 2297 doi: 10.1158/1078-0432.CCR-21-4000
|
| 23 |
Hongping Lu, Ming Han, Xiaoxue Yuan, Kelbinur Tursun, Yu Zhang, Yaru Li, Zhongshu Li, Shenghu Feng, Li Zhou, Zhipeng Pan, Qi Wang, Kai Han, Shunai Liu, Jun Cheng. Role of IL‐6‐mediated expression of NS5ATP9 in autophagy of liver cancer cells. Journal of Cellular Physiology 2018; 233(12): 9312 doi: 10.1002/jcp.26343
|
| 24 |
Yu-De Chu, Hui-Fen Liu, Yi-Chen Chen, Chun-Hung Chou, Chau-Ting Yeh. WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.996820
|
| 25 |
Yuxin Zhou, Yongjian Guo, Yejin Zhu, Yuening Sun, Wei Li, Zhiyu Li, Libin Wei. Dual PPARγ/ɑ agonist oroxyloside suppresses cell cycle progression by glycolipid metabolism switch-mediated increase of reactive oxygen species levels. Free Radical Biology and Medicine 2021; 167: 205 doi: 10.1016/j.freeradbiomed.2021.02.032
|
| 26 |
Waleed M. Elguindy, Waleed M. Serag. Cardiac echoparameters (geometry and dimensions), interleukin 6, and anthropometric measurements in Egyptian adolescents with hepatitis C and hepatocellular carcinoma. Egyptian Liver Journal 2017; 7(3 and 4): 58 doi: 10.1097/01.ELX.0000526967.41371.51
|
| 27 |
Liying Guo, Kai Tan, Hao Wang, Xuan Zhang. Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis. Oncology Reports 2016; 36(6): 3233 doi: 10.3892/or.2016.5151
|
| 28 |
Qiao Zhu, Li Gong, Jun Wang, Qian Tu, Li Yao, Jia-Rui Zhang, Xiu-Juan Han, Shao-Jun Zhu, Shu-Mei Wang, Yan-Hong Li, Wei Zhang. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1). BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2801-4
|
| 29 |
Jun-Fei Li, Xiao-Rong Zheng, Hong-Yan Zhang, Chang-Ming Shen, Guo-xin Shen, Jian-Wei Jiang, Jun Yan Tao. Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-κB-HIF-2α-SerpinB3 Pathway. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1911311
|
| 30 |
Chunxiao Gao, Yuanyuan Ma, Deyue Yan, Lianzhen Chen, Wei Yuan, Jie Ma. Intelligently responsive amphiphilic small molecule loaded with doxorubicin to form highly effective anti-hepatocarcinoma nanomicelles. Materials & Design 2021; 212: 110230 doi: 10.1016/j.matdes.2021.110230
|
| 31 |
Changbo Fu, Xuan Xu, Weijun Lu, Lei Nie, Tao Yin, Dongde Wu. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma. Medicine 2019; 98(42): e17412 doi: 10.1097/MD.0000000000017412
|
| 32 |
Jun Zou, Wan Qin. Comprehensive analysis of the cancer driver genes constructs a seven-gene signature for prediction of survival and tumor immunity in hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.937948
|
| 33 |
Nur Signa A Gumilas, Ika M Harini, Thianty Sylviningrum, Wahyu Djatmiko, Lantip Rujito. Hepatitis B as hepatocellular carcinoma (HCC) risk factor in the south region of Java, Indonesia. Journal of Physics: Conference Series 2019; 1246(1): 012013 doi: 10.1088/1742-6596/1246/1/012013
|
| 34 |
Qing Zhao, Bo Zheng, Shiquan Meng, Ying Xu, Jing Guo, Li-jie Chen, Jian Xiao, Wei Zhang, Zhi-rong Tan, Jie Tang, Lei Chen, Yao Chen. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Biomedicine & Pharmacotherapy 2019; 114: 108864 doi: 10.1016/j.biopha.2019.108864
|
| 35 |
T. Yin, C. B. Fu, D. D. Wu, L. Nie, H. Chen, Y. Wang. Apatinib Suppressed Macrophage-Mediated Malignant Behavior of Hepatocellular Carcinoma Cells via Modulation of VEGFR2/STAT3/PD-L1 Signaling. Molecular Biology 2023; 57(4): 714 doi: 10.1134/S0026893323040180
|
| 36 |
Kelly Goulart Lima, Gabriele Catyana Krause, Aline Daniele Schuster, Anderson Velasque Catarina, Bruno Souza Basso, Fernanda Cristina De Mesquita, Leonardo Pedrazza, Elisa Simon Marczak, Bianca Andrade Martha, Fernanda Bordignon Nunes, Eduardo Cremonese Filippi Chiela, Natália Jaeger, Marcos Paulo Thomé, Gabriela Viegas Haute, Henrique Bregolin Dias, Márcio Vinícius Fagundes Donadio, Jarbas Rodrigues De Oliveira. Gallic acid reduces cell growth by induction of apoptosis and reduction of IL-8 in HepG2 cells. Biomedicine & Pharmacotherapy 2016; 84: 1282 doi: 10.1016/j.biopha.2016.10.048
|
| 37 |
Yueying Li, Xinchi Zhang, Xiaoming Yang, Jun Liu, Linjie Li, Wenbin Ma, Min Chen. Differential effects of ginkgol C17:1 on cisplatin‑induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells. Oncology Letters 2019; doi: 10.3892/ol.2019.9974
|
| 38 |
Yiwei Liu, Hairong Chen, Xiangcheng Li, Feng Zhang, Lianbao Kong, Xuehao Wang, Jin Bai, Xiaofeng Wu. PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.607021
|
| 39 |
Yunwu Wang, Yu Xu, Wei Yan, Ping Han, Jingmei Liu, Jin Gong, Dongxiao Li, Xiangming Ding, Han Wang, Zhuoying Lin, Dean Tian, Jiazhi Liao. CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways. Oncotarget 2018; 9(14): 11783 doi: 10.18632/oncotarget.24364
|
| 40 |
Yubo Tang, Jie Chen, Jiaqi Li, Yifan Zheng, Xiuxiu Zhong, Shuai Huang, Bin Chen, Baogang Peng, Xuenong Zou, Xiao Chen. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway. Phytomedicine 2021; 86: 153563 doi: 10.1016/j.phymed.2021.153563
|
| 41 |
Yuanyuan Gan, Nana Han, Xiaoqin He, Jiajun Yu, Meixia Zhang, Yujie Zhou, Huiling Liang, Junjian Deng, Yongfa Zheng, Wei Ge, Zhixiong Long, Ximing Xu. Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma. Tumor Biology 2017; 39(6): 101042831770622 doi: 10.1177/1010428317706229
|
| 42 |
Peter Dietrich, Kim Freese, Abdo Mahli, Wolfgang Erwin Thasler, Claus Hellerbrand, Anja Katrin Bosserhoff. Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option. Oncotarget 2018; 9(3): 3605 doi: 10.18632/oncotarget.23188
|
| 43 |
Ying Chen, Zetian Shen, Yingru Zhi, Hao Zhou, Kai Zhang, Ting Wang, Bing Feng, Yitian Chen, Haizhu Song, Rui Wang, Xiaoyuan Chu. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression. Archives of Biochemistry and Biophysics 2018; 645: 117 doi: 10.1016/j.abb.2018.03.018
|
| 44 |
Yuan Ding, Zhongquan Sun, Sitong Zhang, Qianhui Xu, Liuzhi Zhou, Dongkai Zhou, Yanjie Li, Xin Han, Hao Xu, Yang Bai, Chang Xu, Hao Ding, Yao Ge, Weilin Wang. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma. Bioscience Reports 2020; 40(7) doi: 10.1042/BSR20201479
|
| 45 |
Yipeng Pan, Bo You, Xue Zhao, Shanxin Zhang, Wei Li. CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12275-w
|
| 46 |
Xianqiong Liu, Junjie Hu, Xinhua Song, Kirsten Utpatel, Yi Zhang, Pan Wang, Xinjun Lu, Jie Zhang, Meng Xu, Tao Su, Li Che, Jingxiao Wang, Matthias Evert, Diego Calvisi, Xin Chen. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers 2019; 11(7): 930 doi: 10.3390/cancers11070930
|
| 47 |
Shunnan Yao, Jianpin Ye, Mengqi Yin, Rui Yu. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo. Cancer Letters 2020; 483: 87 doi: 10.1016/j.canlet.2020.04.003
|
| 48 |
Peter Dietrich, Anne Gaza, Laura Wormser, Valerie Fritz, Claus Hellerbrand, Anja Katrin Bosserhoff. Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma. Neoplasia 2019; 21(3): 257 doi: 10.1016/j.neo.2018.11.011
|
| 49 |
Arif Fadlan, Nila Huda, First Ambar Wati, Nur Pasca Aijijiyah, Azminah Azminah, Mardi Santoso. 3-hydroxy-3-(1H-indol-3-yl)-5-nitrooxindole and derivative. THE FOURTH AL-NOOR INTERNATIONAL CONFERENCE FOR SCIENCE AND TECHNOLOGY (4NICST2022) 2024; 3079: 020039 doi: 10.1063/5.0205816
|
| 50 |
You Lu, Qingyu Xu, Guowen Yin, Weidong Xu, Hao Jiang. Resolvin D1 inhibits the proliferation of lipopolysaccharide‑treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6651
|
| 51 |
Shaolei Wang, Dehua Liu, Hong Wei, Yang Hua, Guodong Shi, Jinhan Qiao. The hsa_circRNA_102049 mediates the sorafenib sensitivity of hepatocellular carcinoma cells by regulating Reelin gene expression. Bioengineered 2022; 13(2): 2272 doi: 10.1080/21655979.2021.2024332
|
| 52 |
Liping Sun, Shuguang Liu, Xiaopai Wang, Xuefeng Zheng, Ya Chen, Hong Shen. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02877-4
|
| 53 |
Li Che, Maria G. Pilo, Antonio Cigliano, Gavinella Latte, Maria M. Simile, Silvia Ribback, Frank Dombrowski, Matthias Evert, Xin Chen, Diego F. Calvisi. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma. Cell Cycle 2017; 16(6): 499 doi: 10.1080/15384101.2017.1282586
|
| 54 |
Li Che, Panagiotis Paliogiannis, Antonio Cigliano, Maria G. Pilo, Xin Chen, Diego F. Calvisi. Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01412
|
| 55 |
|
| 56 |
Shunya Ikeda, Masatoshi Kudo, Namiki Izumi, Masahiro Kobayashi, Mie Azuma, Genevieve Meier, Janice Pan, Mika Ishii, Shuichi Kaneko. Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial. Value in Health Regional Issues 2021; 24: 82 doi: 10.1016/j.vhri.2020.05.009
|
| 57 |
Ming-Huang Chen, Sheng-Nan Lu, Chien-Hung Chen, Peng-Chan Lin, Jeng-Kai Jiang, Yulia D’yachkova, Mariusz Lukanowski, Rebecca Cheng, Li-Tzong Chen. How May Ramucirumab Help Improve Treatment Outcome for Patients with Gastrointestinal Cancers?. Cancers 2021; 13(14): 3536 doi: 10.3390/cancers13143536
|
| 58 |
Tao Han, Xiaodan Yang, Yue Zhang, Gao Li, Lu Liu, Tingsong Chen, Zhendong Zheng. The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis. BioScience Trends 2019; 13(5): 374 doi: 10.5582/bst.2019.01153
|
| 59 |
Ralph Drewes, Constanze Heinze, Maciej Pech, Maciej Powerski, Katja Woidacki, Andreas Wienke, Alexey Surov, Jazan Omari. Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization. Digestive Diseases 2022; 40(5): 596 doi: 10.1159/000520716
|
| 60 |
Rinku Dutta, Ram I. Mahato. Recent advances in hepatocellular carcinoma therapy. Pharmacology & Therapeutics 2017; 173: 106 doi: 10.1016/j.pharmthera.2017.02.010
|
| 61 |
Gian Piero Guerrini, Domenico Pinelli, Elena Marini, Vittorio Corno, Michela Guizzetti, Marco Zambelli, Alessandro Aluffi, Lisa Lincini, Stefano Fagiuoli, Alessandro Lucianetti, Michele Colledan. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation. Progress in Transplantation 2018; 28(1): 63 doi: 10.1177/1526924817746686
|
| 62 |
T. Yin, C. B. Fu, D. D. Wu, L. Nie, H. Chen, Y. Wang. Apatinib Suppressed Macrophage-Mediated Malignant Behavior of Hepatocellular Carcinoma Cells via Modulation of VEGFR2/STAT3/PD-L1 Signaling. Молекулярная биология 2023; 57(4): 706 doi: 10.31857/S0026898423040237
|
| 63 |
Laura Santangelo, Cecilia Battistelli, Claudia Montaldo, Franca Citarella, Raffaele Strippoli, Carla Cicchini. Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/2931813
|
| 64 |
Zhicheng Liu, Dingquan Yang, Yanqing Li, Yan Jiao, Guangchao Lv. HN1 as a diagnostic and prognostic biomarker for liver cancer. Bioscience Reports 2020; 40(7) doi: 10.1042/BSR20200316
|
| 65 |
Zi‐Qi Zhou, Jing‐Jing Zhao, Chang‐Long Chen, Yuan Liu, Jian‐Xiong Zeng, Zheng‐Rong Wu, Yan Tang, Qian Zhu, De‐Sheng Weng, Jian‐Chuan Xia. HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma. Molecular Carcinogenesis 2019; 58(1): 76 doi: 10.1002/mc.22908
|
| 66 |
Wenjie Zheng, Min Yao, Qi Qian, Wenli Sai, Liwei Qiu, Junling Yang, Wei Wu, Zhizhen Dong, Dengfu Yao. Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target. Oncotarget 2017; 8(32): 52321 doi: 10.18632/oncotarget.13674
|
| 67 |
Li-xiang Zhang, Pan-quan Luo, Lei Chen, Dong-da Song, A-man Xu, Peng Xu, Jia Xu. Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.537526
|
| 68 |
B Yurdacan, U Egeli, G Guney Eskiler, IE Eryilmaz, G Cecener, B Tunca. The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma. Human & Experimental Toxicology 2019; 38(2): 201 doi: 10.1177/0960327118792052
|
| 69 |
Xinrui Zhang, Mengya Wang, Shanshan Teng, Di Wang, Xin Li, Xiaofeng Wang, Weiwei Liao, Di Wang. Indolyl-chalcone derivatives induce hepatocellular carcinoma cells apoptosis through oxidative stress related mitochondrial pathway in vitro and in vivo. Chemico-Biological Interactions 2018; 293: 61 doi: 10.1016/j.cbi.2018.07.025
|
| 70 |
Hiroyuki Tomita, Tomohiro Kanayama, Ayumi Niwa, Kei Noguchi, Takuji Tanaka, Akira Hara. Stem Cells and Cancer in Hepatology. 2018; : 273 doi: 10.1016/B978-0-12-812301-0.00013-X
|
| 71 |
Muhammad Afzal, Muhammad Imran, Samen Fatima, Muhammad Iqbal, Farkhanda Gillani, Nayyar Rubab, Owais Gill, Muhammad Naeem. 99mTc-MDP renal parenchymal retention on bone scan in hepatocellular carcinoma patients. Pakistan Journal of Nuclear Medicine 2020; : 31 doi: 10.24911/PJNMed.175-1574674085
|
| 72 |
Colin Yee, David McCoy, Jay Yu, Aaron Losey, Caroline Jordan, Terilyn Moore, Carol Stillson, Hee Jeung Oh, Bridget Kilbride, Shuvo Roy, Anand Patel, Mark W. Wilson, Steven W. Hetts. Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model. Radiology: Imaging Cancer 2019; 1(1): e190009 doi: 10.1148/rycan.2019190009
|
| 73 |
Lei Zheng, Hua Feng, Limin Yin, Jun Wang, Wei Zhou, Sunin Tang, Mingming Li, Gu Xiaoqing. Study on the Correlation Factors of Tumour Prognosis after Intravascular Interventional Therapy. Journal of Healthcare Engineering 2021; 2021: 1 doi: 10.1155/2021/6940056
|
| 74 |
Sarah Jane Commander, Brian Shaw, Laura Washburn, Dor Yoeli, Abbas Rana, John A. Goss. A long‐term experience with expansion of Milan criteria for liver transplant recipients. Clinical Transplantation 2018; 32(6) doi: 10.1111/ctr.13254
|
| 75 |
Nurhisyam Zakaria, Mohamad Azrul Mahdzir, Mahfuzah Yusoff, Norhafiza Mohd Arshad, Khalijah Awang, Noor Hasima Nagoor. Cytotoxic Effects of Pinnatane A Extracted from Walsura pinnata (Meliaceae) on Human Liver Cancer Cells. Molecules 2018; 23(11): 2733 doi: 10.3390/molecules23112733
|
| 76 |
Guannan Wang, Xiaosan Fang, Meng Han, Xiaoming Wang, Qiang Huang. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3358
|
| 77 |
Catia Giovannini, Manuela Minguzzi, Filippo Genovese, Michele Baglioni, Alessandra Gualandi, Matteo Ravaioli, Maddalena Milazzo, Simona Tavolari, Luigi Bolondi, Laura Gramantieri. Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma. Oncotarget 2016; 7(26): 39609 doi: 10.18632/oncotarget.9203
|
| 78 |
Dan-Hong Yang, Wei-Ping Wang, Qiang Zhang, Hong-Ying Pan, Yi-Cheng Huang, Jia-Jie Zhang. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World Journal of Gastroenterology 2021; 27(17): 2025-2038 doi: 10.3748/wjg.v27.i17.2025
|
| 79 |
Xiao-Qin He, Yue-Feng Zhang, Jia-Jun Yu, Yuan-Yuan Gan, Na-Na Han, Mei-Xia Zhang, Wei Ge, Jun-Jian Deng, Yong-Fa Zheng, Xi-Ming Xu. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway. Tumor Biology 2017; 39(3): 101042831769597 doi: 10.1177/1010428317695971
|
| 80 |
Ze-Tian Shen, Ying Chen, Gui-Chun Huang, Xi-Xu Zhu, Rui Wang, Long-Bang Chen. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6312-y
|
| 81 |
Yukari Mizukami, Koji Sugawara, Yukimi Kira, Daisuke Tsuruta. Sorafenib stimulates human skin type mast cell degranulation and maturation. Journal of Dermatological Science 2017; 88(3): 308 doi: 10.1016/j.jdermsci.2017.08.005
|
| 82 |
Peter Dietrich, Claus Hellerbrand, Anja Bosserhoff. The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression. Cancers 2019; 11(3): 398 doi: 10.3390/cancers11030398
|
| 83 |
Peter R. Galle, Masatoshi Kudo, Josep M. Llovet, Richard S. Finn, Mark Karwal, Denis Pezet, Tae‐You Kim, Tsai‐Sheng Yang, Sara Lonardi, Jiri Tomasek, Jean‐Marc Phelip, Yann Touchefeu, Su‐Jin Koh, Guido Stirnimann, Kun Liang, Kenyon D. Ogburn, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu. Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology. Liver International 2021; 41(11): 2759 doi: 10.1111/liv.14994
|
| 84 |
Xiang-Kun Wang, Xu-Dong Zhang, Kai Luo, Long Yu, Shuai Huang, Zhong-Yuan Liu, Ren-Feng Li. Comprehensive analysis of candidate signatures of long non-coding RNA LINC01116 and related protein-coding genes in patients with hepatocellular carcinoma. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02827-y
|
| 85 |
Vahid Mansouri, Nima Rezaei. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 1 doi: 10.1007/16833_2022_70
|
| 86 |
Bing Feng, Ying Zhu, Chaoyue Sun, Zuqing Su, Lipeng Tang, Caiyun Li, Guangjuan Zheng. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. International Journal of Biological Macromolecules 2019; 137: 32 doi: 10.1016/j.ijbiomac.2019.06.189
|
| 87 |
Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell Death & Disease 2022; 13(11) doi: 10.1038/s41419-022-05419-y
|
| 88 |
Jie Wang, Hancong Liu, Liuchong Zhu, Jingyi Wang, Xiongming Luo, Wenbin Liu, Yan Ma. Prodigiosin from Serratia Marcescens in Cockroach Inhibits the Proliferation of Hepatocellular Carcinoma Cells through Endoplasmic Reticulum Stress-Induced Apoptosis. Molecules 2022; 27(21): 7281 doi: 10.3390/molecules27217281
|
| 89 |
Peter Dietrich, Andreas Koch, Valerie Fritz, Arndt Hartmann, Anja Katrin Bosserhoff, Claus Hellerbrand. Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance. Gut 2018; 67(7): 1328 doi: 10.1136/gutjnl-2017-315402
|
| 90 |
Supritha G. Swamy, Vivek H. Kameshwar, Priya B. Shubha, Chung Yeng Looi, Muthu K. Shanmugam, Frank Arfuso, Arunasalam Dharmarajan, Gautam Sethi, Nanjunda Swamy Shivananju, Anupam Bishayee. Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma. Targeted Oncology 2017; 12(1): 1 doi: 10.1007/s11523-016-0452-7
|
| 91 |
Xiaochun Peng, Fengmei Wei, Xiaoli Hu. Long noncoding RNA DLGAP1‐AS1 promotes cell proliferation in hepatocellular carcinoma via sequestering miR‐486‐5p. Journal of Cellular Biochemistry 2020; 121(2): 1953 doi: 10.1002/jcb.29430
|
| 92 |
Nuobei Zhang, Xin Chen. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Cellular Oncology 2020; 43(1): 137 doi: 10.1007/s13402-019-00478-4
|
| 93 |
Vadanasundari Vedarethinam, Karthik Dhanaraj, Soundharrajan Ilavenil, Mariadhas Arasu, Ki Choi, Naif Al-Dhabi, Srigopalram Srisesharam, Kyung Lee, Da Kim, Tamilvenvendan Dhanapal, Ravikumar Sivanesan, Han Choi, Young Kim. Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma. Molecules 2016; 21(5): 632 doi: 10.3390/molecules21050632
|
| 94 |
Diana I. Sánchez, Bárbara González‐Fernández, Beatriz San‐Miguel, Juan Ortiz de Urbina, Irene Crespo, Javier González‐Gallego, María J. Tuñón. RETRACTED: Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1‐phosphate signaling pathway in a mouse model of diethylnitrosamine‐induced hepatocellular carcinoma. Journal of Pineal Research 2017; 62(1) doi: 10.1111/jpi.12369
|
| 95 |
Yu-De Chu, Hsin-Yu Lai, Li-Mei Pai, Ya-Hui Huang, Yang-Hsiang Lin, Kung-Hao Liang, Chau-Ting Yeh. The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionine. Cell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1486-4
|
| 96 |
Dongmei Zhang, Yunzhen Zhou, Yanan Ma, Ping Jiang, Hongchao Lv, Sijia Liu, Yu Mu, Chong Zhou, Shan Xiao, Guohua Ji, Peng Liu, Ning Zhang, Donglin Sun, Haiming Sun, Nan Wu, Yan Jin. Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma. Cell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01153-8
|
| 97 |
Romina Armando, Diego Mengual G�mez, Daniel Gomez. New drugs are not enough‑drug repositioning in oncology: An update. International Journal of Oncology 2020; doi: 10.3892/ijo.2020.4966
|
| 98 |
Yao-Li Chen, Ping-Yi Lin, Ying-Zi Ming, Wei-Chieh Huang, Rong-Fu Chen, Po-Ming Chen, Pei-Yi Chu. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3460-9
|
| 99 |
Lin Zheng, Chen-Yang Guo, Cheng-Shi Chen, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Deng-Wei Zong, Li Jiang, Hai-Liang Li. Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study. Oncotarget 2017; 8(57): 97613 doi: 10.18632/oncotarget.18811
|
| 100 |
Xin Zhou, Tian-Man Li, Jian-Zhu Luo, Chen-Lu Lan, Zhong-Liu Wei, Tian-Hao Fu, Xi-Wen Liao, Guang-Zhi Zhu, Xin-Ping Ye, Tao Peng. CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. Journal of Hepatocellular Carcinoma 2021; : 1323 doi: 10.2147/JHC.S335425
|
| 101 |
Yue Yang, Pingya He, Ning Li. The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/1242784
|
| 102 |
Hai-Mei Guo, Zhi-Feng Zhao, Yu-Qin Che, Jian-Hua Fan. Induction of Apoptosis in the Human HepG2 Hepatoma Cell Line Through the Extrinsic Pathway by Delphinium Alkaloid A. International Journal of Pharmacology 2021; 17(8): 562 doi: 10.3923/ijp.2021.562.571
|
| 103 |
Yuxin Chen, Yanping Wu, Xiao Zhang, Hong Zeng, Ya Liu, Qi Wu, Yan Chen, GuoQing Zhu, Qiuhui Pan, Lei Jin, Lin Guo, Fenyong Sun. Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population. Clinica Chimica Acta 2018; 478: 18 doi: 10.1016/j.cca.2017.12.017
|
| 104 |
|
| 105 |
Antonio Cigliano, Chunmei Wang, Maria G. Pilo, Marta Szydlowska, Stefania Brozzetti, Gavinella Latte, Giovanni M. Pes, Rosa M. Pascale, Maria A. Seddaiu, Gianpaolo Vidili, Silvia Ribback, Frank Dombrowski, Matthias Evert, Xin Chen, Diego F. Calvisi. Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice. Oncotarget 2017; 8(33): 54149 doi: 10.18632/oncotarget.16927
|
| 106 |
Yiwen Hu, Linlin Zhang, Qinghua Qi, Shanshan Ren, Simeng Wang, Lanling Yang, Juan Zhang, Yuanyuan Liu, Xiaoxiao Li, Xiguo Cai, Shaobo Duan, Lianzhong Zhang. Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1464735
|